Has the accuracy of preoperative diagnosis improved in cases of early-stage gastric cancer?
BACKGROUND
Adequate preoperative evaluation for gastric cancer staging is essential to develop an individualized treatment strategy involving surgery with reduced lymphadenectomy and laparoscopic gastrectomy.


METHODS
A total of 509 gastric cancer patients with clinical Stage IA or IB disease were divided into two groups: 304 patients were admitted in 2000 or earlier (Group A), and 205 patients were admitted in 2001, when multidetector computed tomography (MD-CT) was available, or later (Group B). We evaluated the accuracy of the preoperative diagnoses of tumor depth, lymph node involvement, and tumor stage.


RESULTS
With respect to tumor depth, 94.5 and 52.8% of patients were staged correctly in cT1 and cT2 patients, respectively. Among both cT1 and cT2 patients, the underestimated rates were lower in Group B than in Group A. For nodal metastasis, 83.2 and 30.0% of patients were staged correctly in cN0 and cN1 patients, respectively. Among the cN0 patients, 82.1 and 84.7% of Group A and Group B patients, respectively, were staged correctly. Among the cN1 patients, none of the patients in Group B was underestimated, while 9.7% of Group A patients were underestimated. There was a significant increase in the percentage of correctly staged patients and a decrease in the percentage of underestimated patients in Group B in comparison to Group A in both cStage IA and cStage IB patients.


CONCLUSIONS
Remarkable advances have been observed in the accuracy of preoperative staging in the early stage of gastric cancer. However, it is necessary to continue to develop accurate preoperative and intraoperative diagnostic systems.
Tsujimoto
Hironori
H
Department of Surgery, National Defense Medical College, 3-2 Namiki, Tokorozawa, 359-8513, Japan. tsujihi@ndmc.ac.jp
Sugasawa
Hidekazu
H
Ono
Satoshi
S
Ichikura
Takashi
T
Yamamoto
Junji
J
Hase
Kazuo
K
D016009:Chi-Square Distribution; D005260:Female; D005743:Gastrectomy / Q000379:methods*; D006801:Humans; D008207:Lymphatic Metastasis; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging / Q000379:methods*; D011300:Preoperative Care; D018709:Statistics, Nonparametric; D013274:Stomach Neoplasms / Q000000981:diagnostic imaging / Q000473:pathology* / Q000601:surgery*; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
Gastrointest Endosc. 2004 Jul;60(1):50-5
15229425
J Formos Med Assoc. 1996 May;95(5):378-85
8688702
Cancer. 1989 Nov 15;64(10):2053-62
2680049
World J Surg. 2002 Mar;26(3):318-22
11865368
Radiology. 2004 Feb;230(2):465-71
14752188
J Comput Assist Tomogr. 2007 Jan-Feb;31(1):98-103
17259840
Gastric Cancer. 2009;12(1):6-22
19390927
AJR Am J Roentgenol. 2000 Jun;174(6):1551-7
10845479
Hepatogastroenterology. 2008 Mar-Apr;55(82-83):782-5
18613454
Jpn J Surg. 1981 Mar;11(2):127-39
7300058
Surgery. 1988 Mar;103(3):315-20
3278405
Surgery. 2006 Apr;139(4):501-7
16627059
Radiology. 1995 Dec;197(3):705-11
7480743
Gastric Cancer. 2002;5(1):1-5
12021853
Ann Surg Oncol. 2003 Oct;10(8):954-60
14527917
J Clin Oncol. 2007 May 20;25(15):2107-16
17513817
Surgery. 1984 Sep;96(3):511-6
6474356
Cancer. 2005 Jun 1;103(11):2383-90
15856477
Radiology. 2005 Sep;236(3):879-85
16020558
Ann Surg Oncol. 2009 Jun;16(6):1514-9
19290492
Radiology. 1992 Feb;182(2):559-64
1732981
Ann Surg. 2009 Jun;249(6):942-7
19474686
Gastric Cancer. 2001;4(1):34-8
11706625
Gastrointest Endosc. 1997 Sep;46(3):212-6
9378206
Eur Radiol. 2000;10(12):1877-85
11305564
Ann Surg Oncol. 2002 May;9(4):401-5
11986193
Dig Dis Sci. 1990 Nov;35(11):1340-4
2226095
Gastric Cancer. 1998 Dec;1(1):10-24
11957040